Nextech Invest Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 24
- Investments
- 74
- Portfolio
- 19
- Exits
- 37
Nextech Invest General Information
Description
Founded in 1998, Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. The firm prefers to invest in the life science, biotechnology, and oncology sector.
Contact Information
Website
www.nextechinvest.com
Year Founded
1998
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- Bahnhofstrasse 18
- 8001 Zurich
- Switzerland
+41 044 000 00 00
Nextech Invest Investments (74)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Alterome Therapeutics | 19-Jan-2022 | Early Stage VC | 000.00 | Biotechnology | Startup | 00000 000000000 00.0 |
| 0000000 0000000000 | 05-Jan-2022 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | 0000000 000000000 00.0 |
| 000 000000000000 | 04-Oct-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 000000000 00.0 |
| 0000000 000 | 22-Sep-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 00000 00.0 |
| 0000000 | 28-Jul-2021 | 00000 00000 | 00000 | Drug Discovery | Startup | |
| 000000 000000 | 16-Jun-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 000000000 00.0 |
| 000000000 000 | 04-Jun-2021 | 00000 00000 | 0000 | Drug Discovery | Stealth | 00000 000000000 00.0 |
| 00000 000000000000 | 13-May-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 00000 00.0 |
| Boundless Bio | 28-Apr-2021 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue | 00000 00000 00.0 |
| Tyra Biosciences | 31-Mar-2021 | Early Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | 0000000 000000000 00.0 |
Nextech Invest Exits (37)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| EQRx | 17-Dec-2021 | Reverse Merger | 00.00 |
| 0000 00000000000 | 15-Sep-2021 | 000 | 00000 |
| 00000000 000000000 | 01-Aug-2021 | 000000000000000000 | 00.00 |
| 00000000 00000000 | 08-Jan-2021 | 000 | 00000 |
| 0000000000 0000000 | 04-Dec-2020 | 000 | 00000 |
| 0000000 000000000 | 03-Dec-2020 | 000 | 00000 |
| 000000 000 | 09-Oct-2020 | 000 | 00000 |
| 00 000000000000 | 02-Oct-2020 | 000 | 00000 |
| PMV Pharma | 25-Sep-2020 | IPO | 00000 |
| Revolution Medicines | 13-Feb-2020 | IPO | 00000 |
Nextech Invest Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNextech Invest Team (38)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Marco Weibel | Chief Financial Officer | Zurich, Switzerland | |||
| Thomas Lips Ph.D | General Partner | Zurich, Switzerland | |||
| Alfred Scheidegger Ph.D | Founder & Partner | 0 | 0 | Zurich, Switzerland | |
| Jakob Loven Ph.D | Partner | 00 | 0 | 0 | Zurich, Switzerland |
| Rocco Sgobbo | Partner | Zurich, Switzerland |
Nextech Invest Co-Investors (156)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Boxer Capital | 13 | 0 | 0 |
|
|
| Casdin Capital | 00 | 0 | 0 |
|
|
| RA Capital Management | 00 | 0 | 00 |
|
|
| Logos Capital | 0 | 0 | 0 |
|
|
| OrbiMed | 0 | 0 | 0 |
|
|